EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity

Beatrice Polini iD, Caterina Ricardi, Francesca Di Lupo, Massimiliano Runfola iD, Andrea Bacci, Simona Rapposelli iD, Ranieri Bizzarri iD, Marco Scalese, Federica Saponaro iD, Grazia Chiellini iD

Cells · 11.04.2025 · 14 (8) · 580

DOI: 10.3390/cells14080580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 11.04.2025. Verfasst von Beatrice Polini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Via Roma 56, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Diet, High-Fat, Obesity, Anti-Anxiety Agents, Anti-Inflammatory Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in drug development allowed for the identification of THRβ-selective thyromimetic TG68 as a very promising lipid lowering and anti-amyloid agent. In the current study, we first investigated the neuroprotective effects of TG68 on in vitro human models of neuroinflammation and β-amyloid neurotoxicity in order to expand our knowledge of the therapeutic potential of this novel thyromimetic. Subsequently, we examined metabolic and inflammatory profiles, along with cognitive changes, using a high-fat diet (HFD) mouse model of obesity. Our data demonstrated that TG68 was able to prevent either LPS/TNFα-induced inflammatory response or β-amyloid-induced cytotoxicity in human microglial (HMC3) cells. Next, we demonstrated that in HFD-fed mice, treatment with TG68 (10 mg/kg/day; 2 weeks) significantly reduced anxiety-like behavior in stretch–attend posture (SAP) tests while producing a 12% BW loss and a significant decrease in blood glucose and lipid levels. Notably, these data highlight a close relationship between improved serum metabolic parameters and a reduction of anxious behavior. Moreover, TG68 administration was observed to efficiently counteract HFD-altered central and peripheral expressions in mice with selected biomarkers of metabolic dysfunction, inflammation, and neurotoxicity, revealing promising neuroprotective effects. In conclusion, our work provides preliminary evidence that TG68 may represent a novel therapeutic opportunity for the treatment of interlinked diseases such as obesity and neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatObesityAnti-Anxiety AgentsAnti-Inflammatory AgentsHypolipidemic AgentsAnimalsMiceDisease Models, AnimalHumansMaleMice, Inbred C57BLAmyloid beta-PeptidesMicrogliaInflammation

Stichwörter der Autor:innen

anxietymicroglianeurodegenerationneuroinflammationobesitythyromimetics

Substanzen

Anti-Anxiety AgentsAnti-Inflammatory AgentsAmyloid beta-PeptidesHypolipidemic Agents

Autor:innen und Institutionen

  • Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Via Roma 56, 56126 Pisa, Italy.
  • Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
  • Institute of Clinical Physiology, Italian National Research Council, 56124 Pisa, Italy.

ORCID-Profile: Beatrice Polini, Massimiliano Runfola, Simona Rapposelli, Ranieri Bizzarri, Federica Saponaro, Grazia Chiellini

Förderung

  • Pfizer

Zitieren

APA

Polini, B., Ricardi, C., Di Lupo, F., Runfola, M., Bacci, A., Rapposelli, S., Bizzarri, R., Scalese, M., Saponaro, F., & Chiellini, G. (2025). Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity. Cells, 14(8), 580. https://doi.org/10.3390/cells14080580

Vancouver

Polini B, Ricardi C, Di Lupo F, Runfola M, Bacci A, Rapposelli S, et al. Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity. Cells. 2025;14(8):580. doi:10.3390/cells14080580

BibTeX
@article{Polini2025,
  author = {Polini, Beatrice and Ricardi, Caterina and Di Lupo, Francesca and Runfola, Massimiliano and Bacci, Andrea and Rapposelli, Simona and Bizzarri, Ranieri and Scalese, Marco and Saponaro, Federica and Chiellini, Grazia},
  title = {Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {8},
  pages = {580},
  doi = {10.3390/cells14080580}
}
Kostenlos starten →